NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CEO George Lawrence Mikan III sold 12,440 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $6.13, for a total value of $76,257.20. Following the sale, the chief executive officer now directly owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
George Lawrence Mikan III also recently made the following trade(s):
- On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The stock was sold at an average price of $6.93, for a total value of $91,337.40.
- On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total transaction of $11,324.24.
- On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
- On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
- On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.
NeueHealth Trading Up 9.4 %
NYSE NEUE opened at $5.10 on Wednesday. The company has a market cap of $42.25 million, a PE ratio of -0.10 and a beta of 0.56. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a 50 day moving average of $7.16 and a 200-day moving average of $6.01.
Institutional Investors Weigh In On NeueHealth
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada cut their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.
View Our Latest Analysis on NEUE
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- 5 discounted opportunities for dividend growth investors
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Must-Own Stocks to Build Wealth This Decade
- What is MarketRank™? How to Use it
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.